Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia
Fibromyalgia is a chronic debilitating medical syndrome with limited therapeutic options. Pregabalin, an anticonvulsant and α-2-Δ subunit receptor ligand, is one of the anchor drugs approved by the US Food and Drug Administration for the treatment of fibromyalgia. The drug has shown clinically meani...
Saved in:
Published in | Drug, healthcare and patient safety Vol. 8; no. Issue 1; pp. 13 - 23 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2016
Taylor & Francis Ltd Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Fibromyalgia is a chronic debilitating medical syndrome with limited therapeutic options. Pregabalin, an anticonvulsant and α-2-Δ subunit receptor ligand, is one of the anchor drugs approved by the US Food and Drug Administration for the treatment of fibromyalgia. The drug has shown clinically meaningful benefits across multiple symptom domains of fibromyalgia. Efficacy of pregabalin in fibromyalgia pain has been evaluated in at least five high-quality randomized trials, two long-term extension studies, a meta-analysis, a Cochrane database systematic review, and several post hoc analyses. These studies also hint towards a meaningful benefit on sleep, functioning, quality of life, and work productivity. Side effects of pregabalin, although common, are mild to moderate in intensity. They are noted early during therapy, improve or disappear with dose reduction, and are not usually life- or organ threatening. In most patients, tolerance develops to the most common side effects, dizziness, and somnolence, with time. With close clinical monitoring at initiation or dose titration, pregabalin can be effectively used in primary care setting. Pregabalin is cost saving with long-term use and its cost-effectiveness profile is comparable, if not better, to that of other drugs used in fibromyalgia. In the present era of limited therapeutic options, pregabalin undoubtedly retains its role as one of cardinal drugs used in the treatment of fibromyalgia. This review intends to discuss the clinical utility of pregabalin in the management of fibromyalgia with a focus on efficacy, safety, and cost-effectiveness. |
---|---|
AbstractList | Fibromyalgia is a chronic debilitating medical syndrome with limited therapeutic options. Pregabalin, an anticonvulsant and α-2-Δ subunit receptor ligand, is one of the anchor drugs approved by the US Food and Drug Administration for the treatment of fibromyalgia. The drug has shown clinically meaningful benefits across multiple symptom domains of fibromyalgia. Efficacy of pregabalin in fibromyalgia pain has been evaluated in at least five high-quality randomized trials, two long-term extension studies, a meta-analysis, a Cochrane database systematic review, and several post hoc analyses. These studies also hint towards a meaningful benefit on sleep, functioning, quality of life, and work productivity. Side effects of pregabalin, although common, are mild to moderate in intensity. They are noted early during therapy, improve or disappear with dose reduction, and are not usually life- or organ threatening. In most patients, tolerance develops to the most common side effects, dizziness, and somnolence, with time. With close clinical monitoring at initiation or dose titration, pregabalin can be effectively used in primary care setting. Pregabalin is cost saving with long-term use and its cost-effectiveness profile is comparable, if not better, to that of other drugs used in fibromyalgia. In the present era of limited therapeutic options, pregabalin undoubtedly retains its role as one of cardinal drugs used in the treatment of fibromyalgia. This review intends to discuss the clinical utility of pregabalin in the management of fibromyalgia with a focus on efficacy, safety, and cost-effectiveness. Santosh Bhusal,1 Sherilyn Diomampo,1 Marina N Magrey2 1Division of Rheumatology, Metrohealth Medical Center, 2Case Western Reserve University School of Medicine at Metrohealth Medical Center, Cleveland OH, USA Abstract: Fibromyalgia is a chronic debilitating medical syndrome with limited therapeutic options. Pregabalin, an anticonvulsant and α-2-Δ subunit receptor ligand, is one of the anchor drugs approved by the US Food and Drug Administration for the treatment of fibromyalgia. The drug has shown clinically meaningful benefits across multiple symptom domains of fibromyalgia. Efficacy of pregabalin in fibromyalgia pain has been evaluated in at least five high-quality randomized trials, two long-term extension studies, a meta-analysis, a Cochrane database systematic review, and several post hoc analyses. These studies also hint towards a meaningful benefit on sleep, functioning, quality of life, and work productivity. Side effects of pregabalin, although common, are mild to moderate in intensity. They are noted early during therapy, improve or disappear with dose reduction, and are not usually life- or organ threatening. In most patients, tolerance develops to the most common side effects, dizziness, and somnolence, with time. With close clinical monitoring at initiation or dose titration, pregabalin can be effectively used in primary care setting. Pregabalin is cost saving with long-term use and its cost-effectiveness profile is comparable, if not better, to that of other drugs used in fibromyalgia. In the present era of limited therapeutic options, pregabalin undoubtedly retains its role as one of cardinal drugs used in the treatment of fibromyalgia. This review intends to discuss the clinical utility of pregabalin in the management of fibromyalgia with a focus on efficacy, safety, and cost-effectiveness. Keywords: fibrositis, myofascial pain, diffuse pain syndrome, lyrica |
Audience | Academic |
Author | Diomampo, Sherilyn Magrey, Marina N Bhusal, Santosh |
AuthorAffiliation | 2 Case Western Reserve University School of Medicine at Metrohealth Medical Center, Cleveland OH, USA 1 Division of Rheumatology, Metrohealth Medical Center, Cleveland OH, USA |
AuthorAffiliation_xml | – name: 1 Division of Rheumatology, Metrohealth Medical Center, Cleveland OH, USA – name: 2 Case Western Reserve University School of Medicine at Metrohealth Medical Center, Cleveland OH, USA |
Author_xml | – sequence: 1 givenname: Santosh surname: Bhusal fullname: Bhusal, Santosh organization: Division of Rheumatology, Metrohealth Medical Center, Cleveland OH, USA – sequence: 2 givenname: Sherilyn surname: Diomampo fullname: Diomampo, Sherilyn organization: Division of Rheumatology, Metrohealth Medical Center, Cleveland OH, USA – sequence: 3 givenname: Marina N surname: Magrey fullname: Magrey, Marina N organization: Case Western Reserve University School of Medicine at Metrohealth Medical Center, Cleveland OH, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26937205$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl1rFDEUhgep2Fp75b0MCCLorpOvSeZGKOtHCwWF2utwkpzMZpmZbDOzwv57s26tu2ISSMh5zpvk5H1enAxxwKJ4Sao5JVx--HT1_XZ-2wjBxJPijBDZzAirxcnB-rS4GMdVlRtrKFf0WXFK64ZJWomz4m7RhSFY6MrNFLowbd-XI3jczTC4Er3PQbstoy_XCVswkPkyj2mJ5ZQQph6HaRf2waTYb6FrA7wonnroRrx4mM-Luy-ffyyuZjffvl4vLm9mtuZkmnlGpHOCGWGMsVUFzpuGIDLLQHAg4KhqnCFOWTSWVNQy6pXjREpPQFh2XlzvdV2ElV6n0EPa6ghB_96IqdWQpmA71JWUiMpDYxrPgTIFnDtELxTWKBqetT7utdYb06Oz-VkJuiPR48gQlrqNPzWXNRVSZYG3DwIp3m9wnHQfRotdBwPGzajzrStVK1mTjL7-B13FTRpyqTSltBY1V5L_pVrIDwiDj_lcuxPVl6JitKlzeTI1_w-Vu8M-2OwWH_L-UcKbg4QlQjctx9jl_4_DeAy-24M2xXFM6B-LQSq9c5_euU_v3ZfpV4f1e2T_eI39ApXv1cg |
CitedBy_id | crossref_primary_10_1515_sjpain_2023_0038 crossref_primary_10_1016_j_joen_2021_10_004 crossref_primary_10_1002_prp2_418 crossref_primary_10_15406_ppij_2020_08_00273 crossref_primary_10_1080_17460441_2023_2202908 crossref_primary_10_1002_prp2_1102 crossref_primary_10_3166_dea_2022_0211 crossref_primary_10_3389_fphar_2023_1296672 crossref_primary_10_1007_s40744_021_00341_9 crossref_primary_10_1016_j_ejphar_2018_03_011 crossref_primary_10_1093_pm_pnaa303 crossref_primary_10_3390_ijms21217877 crossref_primary_10_2147_CEOR_S392276 crossref_primary_10_1111_anec_12489 crossref_primary_10_1038_s41598_022_16146_x crossref_primary_10_17827_aktd_280530 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2016 Dove Medical Press Limited 2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2016 Bhusal et al. This work is published and licensed by Dove Medical Press Limited 2016 |
Copyright_xml | – notice: COPYRIGHT 2016 Dove Medical Press Limited – notice: 2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2016 Bhusal et al. This work is published and licensed by Dove Medical Press Limited 2016 |
DBID | NPM AAYXX CITATION 3V. 7RV 7XB 88C 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH KB0 M0T M2O MBDVC NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.2147/DHPS.S95535 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Public Health Database (ProQuest Medical & Health Databases) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Nursing & Allied Health Database (Alumni Edition) ProQuest Health Management Database Proquest Research Library Research Library (Corporate) Nursing & Allied Health Premium ProQuest - Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection ProQuest Central Korea ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1179-1365 |
EndPage | 23 |
ExternalDocumentID | oai_doaj_org_article_077ee8fa9b9f4a238a44deef58e6e594 A503296289 10_2147_DHPS_S95535 26937205 |
Genre | Journal Article Review |
GeographicLocations | France United States--US Germany |
GeographicLocations_xml | – name: United States--US – name: France – name: Germany |
GroupedDBID | --- 0YH 53G 5VS 7RV 8C1 8FI 8FJ 8G5 ABUWG ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AQUVI AZQEC BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI C1A CCPQU DIK DWQXO E3Z EBD EBS EJD FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW IPNFZ ITC KQ8 M0T M2O M48 M~E NAPCQ NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC RIG RPM TUS UKHRP VDV AAYXX CITATION TDBHL 3V. 7XB 8FK MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c641t-f317dd53b5bbbc00adfb91ee3c3a54a1ad289db1d8cebc102c32f8d4177f1a5c3 |
IEDL.DBID | RPM |
ISSN | 1179-1365 |
IngestDate | Fri Oct 04 13:04:52 EDT 2024 Tue Sep 17 21:26:45 EDT 2024 Fri Aug 16 07:16:28 EDT 2024 Thu Oct 10 18:04:53 EDT 2024 Thu Feb 22 23:32:32 EST 2024 Wed Oct 25 09:20:03 EDT 2023 Tue Aug 20 22:12:25 EDT 2024 Thu Sep 26 17:49:39 EDT 2024 Sat Sep 28 07:58:15 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Issue 1 |
Keywords | fibrositis lyrica diffuse pain syndrome myofascial pain |
Language | English |
License | The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c641t-f317dd53b5bbbc00adfb91ee3c3a54a1ad289db1d8cebc102c32f8d4177f1a5c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762578/ |
PMID | 26937205 |
PQID | 2226564874 |
PQPubID | 3933168 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_077ee8fa9b9f4a238a44deef58e6e594 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4762578 proquest_miscellaneous_1770868761 proquest_journals_2226564874 gale_infotracmisc_A503296289 gale_infotracacademiconefile_A503296289 gale_healthsolutions_A503296289 crossref_primary_10_2147_DHPS_S95535 pubmed_primary_26937205 |
PublicationCentury | 2000 |
PublicationDate | 2016-01-01 |
PublicationDateYYYYMMDD | 2016-01-01 |
PublicationDate_xml | – month: 01 year: 2016 text: 2016-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
PublicationTitle | Drug, healthcare and patient safety |
PublicationTitleAlternate | Drug Healthc Patient Saf |
PublicationYear | 2016 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove Medical Press |
References | 21316271 - Eur J Pain. 2011 Aug;15(7):741-7 18163497 - Arthritis Rheum. 2008 Jan;58(1):26-35 21765861 - Int J Qual Stud Health Well-being. 2011;6(3):null 20056767 - Rheumatology (Oxford). 2010 Apr;49(4):706-15 24769529 - Ann Pharmacother. 2014 Apr 25;48(8):1077-1081 169541 - Psychosom Med. 1975 Jul-Aug;37(4):341-51 19588419 - Cochrane Database Syst Rev. 2009 Jul 08;(3):CD007076 21332254 - Appl Health Econ Health Policy. 2011 Mar 1;9(2):125-36 21639874 - BMC Musculoskelet Disord. 2011 Jun 03;12:125 23072292 - BMC Musculoskelet Disord. 2012 Oct 17;13:199 23203241 - Mod Rheumatol. 2013 Nov;23(6):1108-15 22688598 - Clin J Pain. 2012 Sep;28(7):609-14 18524684 - J Pain. 2008 Sep;9(9):792-805 24515531 - Arthritis Care Res (Hoboken). 2014 Sep;66(9):1354-63 22339078 - J Med Econ. 2012;15(3):481-92 22503162 - Clin Ther. 2012 May;34(5):1092-102 25078977 - Clin Drug Investig. 2014 Sep;34(9):627-37 10405949 - J Rheumatol. 1999 Jul;26(7):1586-92 24504852 - Pharmacoeconomics. 2014 May;32(5):457-66 23062189 - Arthritis Res Ther. 2012 Oct 12;14(5):R217 19185539 - Sleep Med. 2009 Aug;10(7):766-70 16887010 - Arthritis Res Ther. 2006;8(5):218 16951425 - Int J Qual Health Care. 2006 Oct;18(5):377-82 18576297 - Arthritis Rheum. 2008 Jul 15;59(7):961-7 18188077 - J Occup Environ Med. 2008 Jan;50(1):13-24 7699662 - J Rheumatol. 1995 Jan;22(1):151-6 20147618 - J Clin Pharmacol. 2010 Aug;50(8):941-50 22232085 - Arthritis Care Res (Hoboken). 2012 Apr;64(4):597-606 21965636 - J Rheumatol. 2011 Dec;38(12):2643-52 18400400 - Pain. 2008 Jun;136(3):419-31 15355323 - Eur J Neurosci. 2004 Sep;20(6):1566-76 25529830 - Pain Med. 2015 Jan;16(1):176-85 16171242 - Sleep. 2005 Feb;28(2):187-93 24482637 - Arch Med Sci. 2013 Dec 30;9(6):961-7 23641821 - Syst Rev. 2013 May 04;2:25 12810343 - Seizure. 2003 Jul;12(5):300-6 24815038 - Pain Pract. 2015 Jan;15(1):82-94 20178405 - Curr Med Res Opin. 2010 Apr;26(4):965-75 21685799 - J Occup Environ Med. 2011 Jul;53(7):765-70 20074443 - Clin Exp Rheumatol. 2009 Sep-Oct;27(5 Suppl 56):S67-74 15818684 - Arthritis Rheum. 2005 Apr;52(4):1264-73 9121825 - Pain. 1996 Dec;68(2-3):363-8 22386298 - Reumatol Clin. 2012 May-Jun;8(3):120-7 23748251 - Pain Res Manag. 2013 May-Jun;18(3):119-26 19410509 - Sleep Med. 2009 Jun;10(6):604-10 21644108 - Agri. 2011 Apr;23(2):80-3 17177754 - Pain Pract. 2005 Jun;5(2):85-94 17349056 - BMC Musculoskelet Disord. 2007 Mar 09;8:27 23637545 - Clinicoecon Outcomes Res. 2013 Apr 23;5:171-80 16463418 - Arthritis Rheum. 2006 Feb 15;55(1):86-93 12910242 - Nat Neurosci. 2003 Sep;6(9):925-32 19337283 - Nat Rev Rheumatol. 2009 Apr;5(4):191-9 14558098 - Arthritis Rheum. 2003 Oct;48(10):2916-22 20919892 - Disabil Rehabil. 2010;32(23):1939-47 11690728 - Pain. 2001 Nov;94(2):149-58 18695430 - J Cardiovasc Med (Hagerstown). 2008 Sep;9(9):922-5 25162885 - N Engl J Med. 2014 Aug 28;371(9):796-7 9830884 - Arthritis Care Res. 1998 Oct;11(5):397-404 8823701 - J Rheumatol. 1996 Jul;23(7):1255-62 14633240 - J Sleep Res. 2003 Dec;12(4):291-8 18278830 - J Rheumatol. 2008 Mar;35(3):502-14 |
References_xml | |
SSID | ssj0000392482 |
Score | 2.1355367 |
SecondaryResourceType | review_article |
Snippet | Fibromyalgia is a chronic debilitating medical syndrome with limited therapeutic options. Pregabalin, an anticonvulsant and α-2-Δ subunit receptor ligand, is... Santosh Bhusal,1 Sherilyn Diomampo,1 Marina N Magrey2 1Division of Rheumatology, Metrohealth Medical Center, 2Case Western Reserve University School of... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 13 |
SubjectTerms | Absenteeism Back pain Clinical utility Cost analysis Dosage and administration Drug therapy Fatigue Fibromyalgia Health aspects Heart failure Mental depression Mental health Patients Pregabalin Review Rheumatoid arthritis Rheumatology Safety and security measures Sleep Studies Systematic review |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlp0IpTZ9u0lSFQC91Y1mSbR2TtmHpoRTShdzE6JUGUm_Ibg75952xHHdND70UFgyrMba-0Wi-MaMZxg7Bh9aAVCU4F0olPHUDrDFwbZDsd6mT4IZsi2_NYqm-nuvzrVZflBOWywNn4I6qto2xS2CcSQrQwYBSIcaku9hEbXIlUKG3gqlhD5b0qDp3VjEl5XLlw3nUlufo8-L72cczo_XQ5O2POxqq9v-9N285p3ni5JYnOn3CHo8Ukh_nV99lD2L_lD3K3994Plb0jC3Hgp9XHFcWUe0PfA0p0hX6wCNVjgB_x1eJX9_EC3DIx3uOPySEfMo-p-GEAfXq1x1cXVzCc7Y8_fLj06IcWyiUvlFiUyakByFo6bRzzlcVhOSMiFF6CVqBgIABV3AidD46j2TDyzp1QYm2TQK0ly_YTr_q4yvGUb4OLVQ1-EoBhM5AAF_7yss2yqYq2OE9kvY6V8qwGGEQ4JYAtxnwgp0QypMIlbce_kCl21Hp9l9KL9hb0pHNZ0UnI7XHupK1aXBOBXs_SJCZoqoQ0XzaAOdCBa9mkvszSTQvPx--Xwd2NO-1RVKFPBhjPXyTd9Mw3Ukpa31c3a4tQojhIjobUbCXedlMk64bQ92BEIx2tqBmqMxH-sufQ_Fvhd4Ld9nX_wPGPfYQ-d_4RWmf7WxubuMb5FgbdzCY029K_CVB priority: 102 providerName: Directory of Open Access Journals – databaseName: Public Health Database (ProQuest Medical & Health Databases) dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0vggi1s9orSsUfDE2m93Nx5O01XL4IEI96Nsy-3Ut1OS8uz70v3cmyaUNQuEgcDsh2dmZnd9MZmcYOwDnyxqkSsFanyrhqBtgjo5rgWC_ipUE22Vb_Cxmc_XjXJ8PAbf1kFa53RO7jdq3jmLkh2jHEHogvFZfl39T6hpFX1eHFhoP2SOBgkmtG6oTMcZYMkkPzPtjedSQ5_Db7NfZl7Na6669260h6ur1_78r3zFL05TJOzbo9Bl7OoBHftSv9i57EJrn7EkfeeP9gaIXbD6U-rziKFMEsj_zNcRAV2g8D1QzAtwNbyNfrsICLCLxhuMPoSAf885pOKIr3f65gavFJbxk89Pvv09m6dA8IXWFEps0IjDwXkurrbUuy8BHW4sQpJOgFQjw6Gp5K3zlgnUIM5zMY-WVKMsoQDv5iu00bRPeMI70uS8hy8FlCsBXNXhwucucLIMssoQdbDlpln2NDIO-BTHcEMNNz_CEHROXRxIqbN390a4WZtATk5VlCFWE2tZRAeIJUMqHEHUViqBrlbAPtEamPyU6qqc50pnM6wLnlLBPHQUpKC4VcrQ_Z4BzoVJXE8q9CSUqlpsOb-XADIq9NrdimLCP4zDdSclqTWiv1wZZiI4imhmRsNe92IyTzoua-gIhM8qJQE24Mh1pLi-6st8K7Rbur2_vf6137DFiuiFKtMd2Nqvr8B5x08bud8rxD6l0GZ4 priority: 102 providerName: ProQuest |
Title | Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26937205 https://www.proquest.com/docview/2226564874 https://search.proquest.com/docview/1770868761 https://pubmed.ncbi.nlm.nih.gov/PMC4762578 https://doaj.org/article/077ee8fa9b9f4a238a44deef58e6e594 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-a7mUwRvfttcs8KOxlSWxL8sdjm7ULg5WwLpA3cfpKA4kTkvSh__1OthNi9jYwNlgnbJ3upN-J-wC4RG2yAhnvoVKmx2PtqwEmZLimBPZzlzNUlbfFXTqa8J9TMT0BsY-FqZz2tZr3y8WyX84fKt_K9VIP9n5ig_GvIScNJkkbdKCTMXZkolfLL_NfSepYPF-FZ_B9NL7v3xdCMF-nJkkLX5lFtDaiKl__v6vy0bbUdpk82oNuz-BlAx7Dq_onX8GJLV_Di_rkLawDit7ApEn1uQhJpjzI_hZu0Vn_xNKE1ueMQP0Urly43tgZKkLiZUgXQcHw4Hfumx2Z0qvlEy5mc3wLk9ubP8NRryme0NMpj3c9R8DAGMGUUErpKELjVBFbyzRDwTFGQ6aWUbHJtVWaYIZmicsNj7PMxSg0ewen5aq0HyAk-sRkGCWoI45o8gIN6kRHmmWWpVEAl3tOynWdI0OSbeF5Lz3vZc37AK49lw8kPrF19WK1mclmemWUZdbmDgtVOI6EJ5BzY60TuU2tKHgAn_0cyTpK9KCe8kpELClSGlMAXysKr6A0VcTROs6AxuJTXbUoL1qUpFi63byXA9ko9lYSnCIETFYe_cmXQ7Pv6Z3VSrt63EpiIRmKtM3EAbyvxeYw6L30BZC1BKrFlXYLaUGV9ruR-o__3fMcnhPcaw6QLuB0t3m0nwhS7VQXOvkw7sKz65u78e9udTBB9x9TeueV6y_92Ccm |
link.rule.ids | 230,315,733,786,790,870,891,2115,12250,21416,27955,27956,33299,33300,33777,33778,43612,43838,53825,53827,74369,74657 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF_0-qAg4rex1UYo-GJskt3Nx5O0tuXUehTbg74ts19noSbn3fWh_31nklzaUBAOArcTkp2d2fnNZHaGsR0wNi-Biwi0tpFIDHUDTNFxzRDsF77goJtsi0k2noof5_K8C7gtu7TK9Z7YbNS2NhQj30U7htAD4bX4Ov8XUdco-rratdB4yDao5GYxYhv7h5OT332UJeb0yLQ9mEcteXYPxienX05LKZsGb7emqKnYf39fvmOYhkmTd6zQ0TP2tIOP4V673s_ZA1e9YE_a2FvYHil6yaZdsc_LEKWKYPbncAne0RUqGzqqGgHmOqx9OF-4GWjE4lWIPwSDYZ95TsMenen67zVczi7gFZseHZ59G0dd-4TIZCJZRR6hgbWSa6m1NnEM1usycY4bDlJAAhadLasTWxinDQINw1NfWJHkuU9AGv6ajaq6cm9ZiPSpzSFOwcQCwBYlWDCpiQ3PHc_igO2sOanmbZUMhd4FMVwRw1XL8IDtE5d7Eipt3fxRL2aq0xQV57lzhYdSl14AIgoQwjrnZeEyJ0sRsG1aI9WeE-0VVO3JmKdlhnMK2KeGglQUlwo52p40wLlQsasB5daAElXLDIfXcqA61V6qW0EM2Md-mO6kdLXK1VdLhSxEVxENTRKwN63Y9JNOs5I6AyEz8oFADbgyHKku_jSFvwVaLtxh3_3_tbbZo_HZr2N1_H3yc5M9RoTXxYy22Gi1uHLvEUWt9IdOVW4AQqUeMg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3raxNBEF-0gggiPutptSsU_OKZu9vde3yS2hrig1KogX5bZl-xUO9ikn7of-_M3eXaQxACgeyE3P52Zuc3m9kZxg7AuqICIWMwxsUytdQNMMPANUeyX4ZSgGmzLU7y2Vx-O1fnff7Tuk-r3O6J7UbtGktn5BP0Y0g9kF7LSejTIk6Pp5-Wf2LqIEX_tPbtNO6ye-gVc9Lw8igdzlsSQT-edVf0qDnP5Hh2evbxrFKqbfV245Ta2v3_7tC3XNQ4ffKWP5o-Zo96IskPu5V_wu74-il72J3C8e5y0TM278t-XnLULyLcH_gagqd3qB33VD8C7DVvAl-u_AIMsvKa4wtpIR9y0Gk4YFjd_L6Gy8UFPGfz6ZefR7O4b6QQ21ymmzggSXBOCaOMMTZJwAVTpd4LK0BJSMFh2OVM6krrjUXKYUUWSifToggpKCtesJ26qf1LxlE-cwUkGdhEAriyAgc2s4kVhRd5ErGDLZJ62dXL0BhnEOCaANcd4BH7TCgPIlTkuv2gWS10bzM6KQrvywCVqYIE5BYgpfM-qNLnXlUyYvu0Rrq7MTqYqj5UiciqHOcUsfetBBkrLhUi2t05wLlQ2auR5N5IEo3Mjoe3eqB7I1_rG5WM2LthmL5JiWu1b67WGiHEoBFdThqx3U5thklneUU9ghCMYqRQI1TGI_XFr7YEuEQfhnvtq_8_1j67jzaif3w9-f6aPUCq1x8e7bGdzerKv0E6tTFvWzv5C3djIMw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+utility%2C+safety%2C+and+efficacy+of+pregabalin+in+the+treatment+of+fibromyalgia&rft.jtitle=Drug%2C+healthcare+and+patient+safety&rft.au=Bhusal%2C+Santosh&rft.au=Diomampo%2C+Sherilyn&rft.au=Magrey%2C+Marina+N&rft.date=2016-01-01&rft.issn=1179-1365&rft.eissn=1179-1365&rft.volume=8&rft.spage=13&rft_id=info:doi/10.2147%2FDHPS.S95535&rft_id=info%3Apmid%2F26937205&rft.externalDocID=26937205 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1179-1365&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1179-1365&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1179-1365&client=summon |